Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

6.02
+0.11001.86%
Volume:207.54K
Turnover:1.25M
Market Cap:308.67M
PE:-1.78
High:6.08
Open:5.86
Low:5.80
Close:5.91
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:0.40
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.90
PE(LYR):6.47

Loading ...

Emergent BioSolutions - Awarded Standing Offer to Supply Narcan Nasal Spray in Canada

THOMSON REUTERS
·
Yesterday

Emergent BioSolutions - Standing Offer Effective Oct 1, 2026-Sept 30, 2029 with Two-Year Extension Option

THOMSON REUTERS
·
Yesterday

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

GlobeNewswire
·
Yesterday

August 2026's Highlighted Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 25

Emergent BioSolutions reinstated with an Underweight at JPMorgan

TIPRANKS
·
Aug 21

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Reuters
·
Aug 21

Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek Files Initial Beneficial Ownership Statement

Reuters
·
Aug 12

Emergent Biosolutions is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 10

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

SIGA Technologies Q2 Revenue, Profit Drop as Contract Ends

Reuters
·
Aug 07

INmune Bio Q2 Net Loss Narrows on Lower Impairment Charges

Reuters
·
Aug 07

Sector Update: Healthcare

MT Newswires Live
·
Aug 07

Emergent BioSolutions Shares Plunge After 2026 Guidance Cut, Restructuring

MT Newswires Live
·
Aug 07

Emergent BioSolutions Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Emergent BioSolutions Announces Restructuring Amid Turnaround Efforts

TIPRANKS
·
Aug 06

Emergent BioSolutions Q2 Adj. EPS $0.60 Beats $0.11 Estimate, Sales $234.300M Beat $177.500M Estimate

Benzinga Earnings
·
Aug 06

Emergent BioSolutions Swings to Q2 Loss on Impairment Charge; to Cut Jobs

Reuters
·
Aug 06

Emergent BioSolutions Q2 Revenue USD 234.3 Million

Reuters
·
Aug 06

Emergent BioSolutions Q2 Adjusted EPS USD 0.6

THOMSON REUTERS
·
Aug 06

Emergent BioSolutions Q2 Gross Margin 50%

THOMSON REUTERS
·
Aug 06